Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.36B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.04B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$951M |
| 4 |
Airbnb
ABNB
|
+$942M |
| 5 |
Kenvue
KVUE
|
+$704M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.7B |
| 2 |
Uber
UBER
|
+$901M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$855M |
| 4 |
Illumina
ILMN
|
+$674M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$637M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.54% |
| 2 | Healthcare | 10.41% |
| 3 | Financials | 10.2% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EDD
2676
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$377M
| $16.1M | ﹤0.01% |
3,780,841
+331,931
| +10% | +$1.56M |
|
2677
Tandem Diabetes Care
TNDM
$1.38B
| $16.1M | ﹤0.01% |
774,643
+371,356
| +92% | +$10.2M |
|
2678
Usana Health Sciences
USNA
$422M
| $16.1M | ﹤0.01% |
273,864
+69,085
| +34% | +$4.32M |
|
2679
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.07B
| $16M | ﹤0.01% |
169,793
+31,853
| +23% | +$3.16M |
|
2680
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.52B
| $16M | ﹤0.01% |
823,395
+356,858
| +76% | +$7.1M |
|
2681
Rocket Pharmaceuticals
RCKT
$372M
| $16M | ﹤0.01% |
778,751
+276,627
| +55% | +$5.03M |
|
2682
CRISPR Therapeutics
CRSP
$4.88B
| $16M | ﹤0.01% |
351,435
-39,405
| -10% | -$2.04M |
|
2683
Century Communities
CCS
$1.96B
| $15.9M | ﹤0.01% |
238,685
+16,055
| +7% | +$1.17M |
|
2684
BlackRock Energy and Resources Trust
BGR
$416M
| $15.9M | ﹤0.01% |
1,215,693
-30,423
| -2% | -$384K |
|
2685
JPMorgan Diversified Return International Equity ETF
JPIN
$368M
| $15.9M | ﹤0.01% |
315,262
-3,818
| -1% | -$200K |
|
2686
Harmonic Inc
HLIT
$1.28B
| $15.9M | ﹤0.01% |
1,654,795
-355,301
| -18% | -$4.24M |
|
2687
JFrog
FROG
$9.98B
| $15.9M | ﹤0.01% |
627,485
+187,769
| +43% | +$5.21M |
|
2688
TTEC Holdings
TTEC
$122M
| $15.9M | ﹤0.01% |
605,800
+253,421
| +72% | +$7.62M |
|
2689
iShares Global Consumer Staples ETF
KXI
$1.06B
| $15.9M | ﹤0.01% |
278,189
-39,719
| -12% | -$2.39M |
|
|
BRSL
2690
Brightstar Lottery PLC
BRSL
$1.86B
| $15.9M | ﹤0.01% |
522,809
-106,262
| -17% | -$3.39M |
|
|
MHI
2691
DELISTED
Pioneer Municipal High Income Fund
MHI
| $15.8M | ﹤0.01% |
2,190,747
+194,555
| +10% | +$1.59M |
|
|
CHI
2692
Calamos Convertible Opportunities and Income Fund
CHI
$1.03B
| $15.8M | ﹤0.01% |
1,500,775
+20,249
| +1% | +$220K |
|
2693
Sigma Lithium
SGML
$1.17B
| $15.8M | ﹤0.01% |
487,592
+82,324
| +20% | +$2.95M |
|
2694
Constellium
CSTM
$3.85B
| $15.8M | ﹤0.01% |
868,926
-115,432
| -12% | -$2.04M |
|
|
PEO
2695
Adams Natural Resources Fund
PEO
$739M
| $15.8M | ﹤0.01% |
710,120
-41,428
| -6% | -$897K |
|
2696
TRI-Continental Corp
TY
$1.87B
| $15.7M | ﹤0.01% |
591,208
-57,695
| -9% | -$1.59M |
|
2697
iShares Morningstar Small-Cap Growth ETF
ISCG
$988M
| $15.7M | ﹤0.01% |
405,160
+62,243
| +18% | +$2.56M |
|
2698
Greenlight Captial
GLRE
$552M
| $15.7M | ﹤0.01% |
1,460,958
-44,738
| -3% | -$482K |
|
2699
TG Therapeutics
TGTX
$7.07B
| $15.7M | ﹤0.01% |
1,876,680
+186,498
| +11% | +$2.6M |
|
2700
UFP Technologies
UFPT
$2.07B
| $15.7M | ﹤0.01% |
97,016
-11,854
| -11% | -$2.08M |
|
Similar funds
Morgan Stanley's Q3 2023 Portfolio in Review
As of Q3 2023, Morgan Stanley held 7,879 positions worth $983B, down 3.1% from $1.01T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Morgan Stanley's Q3 2023 filing shows 220 new, 3,248 increased, 3,222 reduced and 253 closed positions. Its largest new stake was TKO Group: 3,583,743 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.7B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2023 buy was TKO Group: 3,583,743 shares worth $301M.
- Morgan Stanley added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $2.36B increase.
- Morgan Stanley's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.7B.
- Morgan Stanley fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $432M.
- Morgan Stanley's ten largest holdings make up 18% of its $983B portfolio in Q3 2023.
- Morgan Stanley opened 220 new positions and closed 253 in Q3 2023.
- Morgan Stanley's portfolio value fell 3.1% quarter-over-quarter to $983B.
Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.